Vigadrone Powder, For Solution
Product Images NDC 0245-0556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigadrone (NDC 0245-0556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Structural Formula For Vigabatrin, A Racemate Consisting Of Two Enantiomers, Is (±) 4 Amino-5 Hexenoic Acid. The Molecular Formula Is C6h11no2 And The Molecular Weight Is 129.16. (Vigadrone 01)

The Structural Formula For Vigabatrin, A Racemate Consisting Of Two Enantiomers, Is (±) 4 Amino-5 Hexenoic Acid. The Molecular Formula Is C6h11no2 And The Molecular Weight Is 129.16. (Vigadrone 01)
FDA Label Image

Figure 1. percent Reduction From Baseline In Seizure Frequency (Vigadrone 02)

Figure 1. percent Reduction From Baseline In Seizure Frequency (Vigadrone 02)
FDA Label Image

Figure 2. percent Reduction From Baseline In Seizure Frequency (Vigadrone 03)

Figure 2. percent Reduction From Baseline In Seizure Frequency (Vigadrone 03)
FDA Label Image

All People Who Take Vigadrone (Vigadrone 04)

All People Who Take Vigadrone (Vigadrone 04)
This is a warning for individuals taking VIGADRONE, a medication that poses a risk of permanent vision loss. The risk increases based on the dosage of VIGADRONE taken daily and the duration of the medication regimen, and there is no way for healthcare providers to predict when vision loss may occur. Vision loss could happen shortly after beginning treatment or at any point during or after treatment.*
FDA Label Image

Supplies You Will Need To Mix 1 Dose Of Vigadrone: (Vigadrone 05)

Supplies You Will Need To Mix 1 Dose Of Vigadrone: (Vigadrone 05)
FDA Label Image

Oral Syringe Detail (Vigadrone 06)

Oral Syringe Detail (Vigadrone 06)
FDA Label Image

Figure A (Vigadrone 07)

Figure A (Vigadrone 07)
FDA Label Image

Figure B (Vigadrone 08)

Figure B (Vigadrone 08)
FDA Label Image

Figure C (Vigadrone 09)

Figure C (Vigadrone 09)
FDA Label Image

Figure D (Vigadrone 0a)

Figure D (Vigadrone 0a)
FDA Label Image

Figure E (Vigadrone 0b)

Figure E (Vigadrone 0b)
FDA Label Image

Figure F (Vigadrone 0c)

Figure F (Vigadrone 0c)
FDA Label Image

Figure G (Vigadrone 0d)

Figure G (Vigadrone 0d)
FDA Label Image

Figure H (Vigadrone 0e)

Figure H (Vigadrone 0e)
FDA Label Image

Figure I (Vigadrone 0f)

Figure I (Vigadrone 0f)
FDA Label Image

Figure J (Vigadrone 10)

Figure J (Vigadrone 10)
FDA Label Image

Ndc 0245-0556-50vigadrone® (vigabatrin) For Oral Solution500 mg50 Single-dose Packetsrx Only (Vigadrone 11)

Ndc 0245-0556-50vigadrone® (vigabatrin) For Oral Solution500 mg50 Single-dose Packetsrx Only (Vigadrone 11)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.